LEIDEN, The Netherlands – July 11, 2018 (Investorideas.com Newswire) Pioneering cannabis science firm ebbu has released findings from its innovative clinical research into the mood effects of cannabis. These findings were presented this week at the 28th annual conference for the International Cannabinoid Research Society (ICRS), where the world’s foremost cannabis researchers convened to discuss ongoing studies and findings with their peers, gain valuable feedback and forge partnerships with the goal of developing a deeper understanding of how the body processes and is affected by cannabis.
“The results of our human observational studies have exceeded our expectations,” said Jon Cooper, CEO of ebbu. “The primary objective in our research is to define how certain cannabinoid and terpene formulations will produce desirable sensations, whether it’s an uptick in stimulating energy, a calming effect or another emotional experience.”
For the second year in a row at the prestigious ICRS conference, ebbu Director
... read more at: http://www.investorideas.com/news/2018/cannabis/07113ebbu.asp